How well does vaccine literacy predict intention to vaccinate and vaccination status? A systematic review and meta-analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 4, 2024 Category: Allergy & Immunology Authors: Claudia IsonneJessica IeraAntonio SciurtiErika RenziMaria Roberta De BlasiisCarolina MarzuilloPaolo VillariValentina BaccoliniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy Source Type: research

Hypophysitis after COVID-19 vaccination in a patient with Rathke ’s cleft cyst: A case report
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 4, 2024 Category: Allergy & Immunology Authors: Yuanyuan YuGuangxin ZhouJunjie DuHuijuan ZhuHaojun GuanYongmin BiDa Zhanga Department of Endocrinology, Air Force Medical Center, Air Force Medical University, Beijing, Chinab Department of Endocrinology, Yulin Traditional Chinese Medicine Hospital, Yulin Source Type: research

The association of caregiver attitudes, information sources, and trust with HPV vaccine initiation among adolescents
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 4, 2024 Category: Allergy & Immunology Authors: Akila AnandarajahThembekile ShatoSarah HumbleAlan R. BarnetteHeather M. BrandtLisa M. KlesgesVetta L. Sanders ThompsonMichelle I. Silvera Department of Surgery (Division of Public Health Sciences), Washington University School of Medicine, Washington Univ Source Type: research

Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 4, 2024 Category: Allergy & Immunology Authors: Georgina TzanakakiHana Cabrnochov áSnežana DelićAnca DraganescuAnna HilfanovaBeáta OnozóMarko PokornAnna SkoczyńskaGoran Tešovića Public Health Microbiology, National Meningitis Reference Laboratory, Laboratory for Surveillance of Infectious Disea Source Type: research

Hotspot areas of tetanus-unprotected births and its associated factors in Ethiopia: Spatial analysis of EDHS data
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 4, 2024 Category: Allergy & Immunology Authors: Anteneh Mengist DessieMelkamu Aderajew ZemeneAsaye Alamneh GebeyehuNatnael Atnafu GebeyehuGetachew Asmare AdellaGizachew Ambaw KassieMisganaw Asmamaw MengstieMohammed Abdu SeidEndeshaw Chekol AbebeMolalegn Mesele GeseseYenealem Solomon KebedeNatnael Moges Source Type: research

The urban-poor vaccination: Challenges and strategies in low-and-middle income countries
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 3, 2024 Category: Allergy & Immunology Authors: Boston ZimbaSamuel MpinganjiraTakondwa MsosaFanuel Meckson Bicktona Department of Public Health, University of Glasgow, Glasgow, UKb Department of Public Health, Kamuzu University of Health Sciences, Blantyre, Malawic Lung Health Group, Malawi-Liverpool-W Source Type: research

Toll-like receptor agonists as cancer vaccine adjuvants
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 29, 2023 Category: Allergy & Immunology Authors: Donghwan JeonEthan HillDouglas G. McNeela Department of Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI, USAb Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI, USA Source Type: research

Wilms ’ tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 27, 2023 Category: Allergy & Immunology Authors: Masahiro OgasawaraDepartment of Internal Medicine, Sapporo Hokuyu Hospital, Sapporo, Japan Source Type: research

Long-lasting complete response to SHR-1701 plus famitinib in refractory advanced gallbladder cancer: A case report
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 21, 2023 Category: Allergy & Immunology Authors: Lixia YiXiaoyan ZhuJing XieZhiqiang Menga Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, Chinab Department of Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, Chinac Department o Source Type: research

Autologous engineered T cell receptor therapy in advanced cancer
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 20, 2023 Category: Allergy & Immunology Authors: Apostolia M. TsimberidouMehmet A. BaysalAbhijit ChakrabortyBorje S. Anderssona Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAb Department of Stem Cell Transplantation and Cellular The Source Type: research

Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 20, 2023 Category: Allergy & Immunology Authors: Lisa HenningMichael AndersonCheryl TriplettTammy SmithKevin BoyceLindsay HendeyAlex RidenourJason EngDavid SchaeufeleEhran WilsonCarol L. SabourinLily E. AdamsTahar BabasLindsay ParishDaniel Wolfea Battelle Biomedical Research Center, Columbus, OH, USAb T Source Type: research

Short-term and long-term behavioral effects of vaccination mandates
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 20, 2023 Category: Allergy & Immunology Authors: Onur BaserKatarzyna RodchenkoLu ChenNehir Yapara Department of Economics, Bogazici University, Istanbul, Turkeyb Graduate School of Public Health, City University of New York, New York, NY, USAc Health Economics and Outcomes Research, Columbia Data Analyt Source Type: research

Humoral response against spike protein and fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects: What should be for the seventh dose?
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 19, 2023 Category: Allergy & Immunology Authors: Somsri WiwanitkitViroj Wiwanitkita Private Academic and Editorial Consultant, Bangkok, Thailandb Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, India Source Type: research

Comparing the immune response and protective effect of COVID-19 vaccine under different vaccination strategies
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 19, 2023 Category: Allergy & Immunology Authors: Tianyi ZhaoXiaoping HuangYuelong Shua School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, Chinab Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Source Type: research

Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - December 19, 2023 Category: Allergy & Immunology Authors: Adriana EfronAlessia BiolchiCecilia Sorhouet PereiraSara TomeiJosefina CamposDenise De BelderMar ía Alicia MoscoloniMauricio SantosGabriela VidalFlorencia NocitaCarla VizzottiMariagrazia Pizzaa Instituto Nacional de Enfermedades Infecciosas-ANLIS “Dr. Source Type: research